Eric Zimmermann, M.D., led research when he was at New York-Presbyterian Queens Hospital that found heart surgery patients may do better if they have their own blood recycled during their procedure.

George Keepers, M.D., is quoted as saying “solid evidence” is needed before psychedelic medicine is adopted in a story about Portland becoming home to one of the first U.S. legal pilot programs to use ecstasy-assisted therapy to treat PTSD patients.

Oregon Senate Bill 638 would require research organizations to make lab animals available for adoption. OHSU’s response was included in the story, noting the university “has in place a robust policy that allows some animals to be considered for adoption when certain public and environmental safety requirements are met."

A Letter to the Editor, written by Danny Jacobs, M.D., M.P.H., addresses the need widespread vaccination. He says, “Individuals who decline vaccination for nonmedical reasons are endangering the health, and in some cases the lives, of our most vulnerable citizens, including the elderly, the very young and the immunocompromised.”

KGW-TV meteorologist Matt Zaffino discusses his recent melanoma surgery and thanks his OHSU surgical team, which included Anna Bar, M.D.

In an interview with HemOnc Today, Donald Sullivan, M.D., discusses why suicide rates are higher for patients with lung and head and neck cancers: “One of the biggest things is that prognoses among these cancer types appear to be poor — they are often found at advanced stage,” he says.

The Chicago Tribune profiles a Chicago-area health system that plans to offer extensive genetic testing to 10,000 primary care patients to determine whether they’re at higher risk of developing certain conditions; Adam Obley, Ph.D. says, “One of the things we worry about is being awash in this information, much of which we don’t know the significance of, could crowd out really important tasks primary care (doctors) need to do.”

Elmo and cast members of Sesame Street Live! stopped by OHSU Doernbecher to visit with patients and their families.

Stephen David, Ph.D., shares his advice with Nature on the importance of postdoctoral mentorship.

Paula Amato, M.D., discusses a Greek clinical trial using germline therapy technology that was originally developed at OHSU. “We are hopeful that continued success abroad will lead Congress to reconsider its ban on mitochondrial replacement therapy trials in the U.S. so that Americans can have access to this promising technology,” she says.